du Bois Score for Idiopathic Pulmonary Fibrosis (IPF) Mortality
The du Bois Score estimates 1‑year mortality risk in IPF using age, recent respiratory hospitalization, baseline FVC%, and 24‑week FVC change.
Indications for Use
Used to estimate 1‑year mortality risk in IPF using age, recent respiratory hospitalization, baseline FVC%, and 24‑week FVC change, the four validated predictors from the du Bois clinical model (C‑statistic 0.75 in 1,099 trial patients) 1 [Level I evidence].
Clinical utility: risk‑stratification, timing of antifibrotic therapy, transplant referral, and prognostic counseling in established IPF.
Insights & Cautions
Predicts 1‑year mortality using age, baseline FVC% and 24‑week FVC change, plus recent respiratory hospitalization, but accuracy is modest and derived from clinical trial cohorts 1 [Level II evidence]. Use cautiously because external validation is limited, progression is heterogeneous, and newer multidimensional models (e.g., GAP, longitudinal GAP) often outperform it for individualized risk estimation 2 [Level II evidence].